Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Moran, Antoinette, Prof, Bundy, Brian, PhD, Becker, Dorothy J, Prof, DiMeglio, Linda A, MD, Gitelman, Stephen E, Prof, Goland, Robin, Prof, Greenbaum, Carla J, MD, Herold, Kevan C, Prof, Marks, Jennifer B, Prof, Raskin, Philip, Prof, Sanda, Srinath, MD, Schatz, Desmond, Prof, Wherrett, Diane K, MD, Wilson, Darrell M, Prof, Krischer, Jeffrey P, Prof, Skyler, Jay S, Prof, Pickersgill, Linda, MD, de Koning, Eelco, Prof, Ziegler, Anette-G, Prof, Böehm, Bernhard, Prof, Badenhoop, Klaus, Prof, Schloot, Nanette, MD, Bak, Jens Friis, MD, Pozzilli, Paolo, Prof, Mauricio, Didac, MD, Donath, Marc Y, Prof, Castaño, Luis, Prof, Wägner, Ana, MD, Lervang, Hans Henrik, MD, Perrild, Hans, MD, Mandrup-Poulsen, Thomas, Prof
Published in The Lancet (British edition) (01.06.2013)
Published in The Lancet (British edition) (01.06.2013)
Get full text
Journal Article
Nuclear factor–κB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma
Gallel, Pilar, MD, Pallares, Judit, MD, PhD, Dolcet, Xavier, PhD, Llobet, David, PhD Student, Eritja, Nuria, PhD Student, Santacana, Maria, PhD Student, Yeramian, Andre, PhD, Palomar-Asenjo, Victor, MD, Lagarda, Helena, MD, Mauricio, Didac, MD, PhD, Encinas, Mario, PhD, Matias-Guiu, Xavier, MD
Published in Human pathology (01.07.2008)
Published in Human pathology (01.07.2008)
Get full text
Journal Article